Posted on June 5, 2011 by Sitemaster
As we have previously reported, the latest analysis of survival data from the pivotal Phase III trial of abiraterone acetate + predisone has shown a slight improvement in the survival benefit for patients treated with abiraterone (Zytiga™). … READ MORE …
Filed under: Drugs in development, Management, Treatment | Tagged: abiraterone, circulating tumor cell, CTC, survival, Zytiga | Leave a comment »
Posted on March 2, 2009 by Sitemaster
New reports today address:
- Positive surgical margins: RALP vs. RRP
- Circulating tumor cells levels and survival of castration-resistant prostate cancer patients
- Patient preference and management of post-surgical incontinence … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: circulating tumor cell, CTC, incontinence, positive surgical margin, preference, prostatectomy, RALP, RRP | 4 Comments »
